Patient info Open main menu

Azacitidine 200 mg film-coated tablets – patient leaflet, side effects, dosage

Last updated: · Text from the MHRA, as of · About this document

Medicine status: Prescription only (POM) Details

Medicine strength:
200 mg
Contains active substance:

Patient leaflet - Azacitidine 200 mg film-coated tablets

1. What Azacitidine is and what it is used for

What Azacitidine is

Azacitidine is an anti-cancer medicine that belongs to a group of medicines called anti-metabolites. Azacitidine contains the active substance azacitidine.

What Azacitidine is used for

Azacitidine is used to treat adults with acute myeloid leukaemia (AML). This is a form of cancer which affects your bone marrow and can cause problems with producing normal blood cells.

Azacitidine is used to keep the disease in control (remission, when the disease is less severe or not active).

How Azacitidine works

Azacitidine works by preventing cancer cells from growing. Azacitidine, the active substance in Azacitidine, works by altering the way the cell turns genes on and off. It also reduces the production of new genetic material (RNA and DNA). These effects are thought to block growth of cancer cells in leukaemia.

Talk to your doctor or nurse if you have any questions about how Azacitidine works or why this medicine has been prescribed for you.

2. What you need to know before you take Azacitidine

Do not take Azacitidine if you are:

  • allergic to azacitidine or any of the other ingredients of this medicine (listed in section 6)
  • breast-feeding.

Warnings and precautions

Blood tests

You will have blood tests before you begin treatment with Azacitidine and during treatment with Azacitidine to check that you have enough blood cells and that your liver and kidneys are working properly. Your doctor will decide how often you have blood tests.

Tell your doctor, pharmacist or nurse straight away if you get any of these symptoms during treatment with Azacitidine:

  • bruising or bleeding - this could be due to a low count of blood cells called platelets
  • fever - this could be due to an infection as a result of having low levels of white blood cells, which can be life-threatening
  • diarrhoea, vomiting or nausea (feeling sick).

Your doctor may need to change the dose, interrupt treatment or stop treatment with Azacitidine completely. The doctor may prescribe other medicines to help manage these symptoms.

Children and adolescents

Azacitidine is not recommended for use in children and adolescents below the age of 18.

Other medicines and Azacitidine

Tell your doctor if you are taking, have recently taken or might take any other medicines. This is because Azacitidine might affect the way some other medicines work. Also, some other medicines may affect the way Azacitidine works.

Pregnancy, contraception and breast-feeding

If you are pregnant or breast-feeding, you think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking this medicine. Men should not father a child while receiving treatment with Azacitidine.

Pregnancy

Do not take Azacitidine during pregnancy as it may be harmful to your baby. Tell your doctor straight away if you become pregnant during treatment.

Contraception

If you are a woman who can become pregnant you should use an effective method of contraception while taking Azacitidine and for 6 months after stopping treatment with Azacitidine. Men should use an effective method of contraception while taking Azacitidine and for 3 months after stopping treatment with Azacitidine.

Your doctor will discuss with you the most suitable method of contraception for you to use.

Breast-feeding

Do not breast-feed while taking Azacitidine as it may be harmful to your child.

Fertility

Azacitidine might affect your ability to have a baby. Talk to your doctor for advice before using it.

Driving and using machines or tools

You may feel tired, weak or have trouble concentrating. If this happens to you or if you have other side effects, do not drive or use any machines or tools.

Azacitidine tablets contain lactose

Azacitidine tablets contain lactose. If you have been told by your doctor that you have intolerance to some sugars, contact your doctor before taking this medicine.

Azacitidine tablets contain sodium

This medicine contains less than 1 mmol sodium (23 mg) per tablet, that is to say essentially ‘sodium-free’.

3. How to take Azacitidine

Always take this medicine exactly as your doctor has told you. Check with your doctor if you are not sure.

How much to take

  • The recommended dose is 300 mg taken by mouth once daily.
  • Your doctor may reduce your dose to 200 mg once daily.

Azacitidine is given in treatment cycles of 28 days.

  • You take Azacitidine every day for the first 14 days of each 28-day cycle.
  • This is followed by a treatment-free period of 14 days for the rest of the cycle.

Your doctor will tell you what dose of Azacitidine to take. The doctor may decide to:

  • extend your treatment beyond 14 days in each treatment cycle
  • lower your dose or temporarily stop treatment
  • reduce your treatment to 7 days.

Always take Azacitidine as prescribed by your doctor.

Your doctor will give you a medicine that helps to reduce nausea (feeling sick) and vomiting. You take it 30 minutes before each Azacitidine tablet, during your first and second treatment cycles. Your doctor will tell you to take it for a longer period, if you need it.

Taking this medicine

  • Take Azacitidine tablets once a day - at the same time each day.
  • Swallow the tablets whole with a full glass of water.
  • To make sure you get the right dose, do not break, crush, dissolve or chew the tablets.
  • You can take the medicine with food or between meals.

If you vomit after taking a tablet, do not take another dose on the same day. Instead, wait till the next day and take your next scheduled dose then. Do not take two doses on the same day.

If powder from a broken tablet touches your skin, wash the skin straight away and thoroughly with soap and water. If the powder gets into your eyes, nose or mouth, flush the area thoroughly with water.

If you take more Azacitidine than you should

If you take more tablets than you should, contact your doctor or go to a hospital straightaway. If possible, take the medicine pack and this leaflet with you.

If you forget to take Azacitidine

If you forget to take Azacitidine at the usual time, take your usual dose as soon as you remember on the same day and take your next dose at the usual time the next day. Do not take a double dose to make up for a forgotten or vomited tablet.

If you stop taking Azacitidine

Do not stop taking Azacitidine unless your doctor tells you to.

If you have any further questions on the use of this medicine, ask your doctor.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Serious side effects

Tell your doctor, pharmacist or nurse straight away if you get any of these symptoms during treatment with Azacitidine:

  • bruising or bleeding - this could be due to a low count of blood cells called platelets
  • fever - this could be due to an infection as a result of having low levels of white blood cells, which can be life-threatening
  • diarrhoea, vomiting or nausea (feeling sick).

Other side effects include:

Very common side effects (may affect more than 1 in 10 people):

  • constipation
  • pain in your belly
  • infections of the nose, sinuses and throat
  • infection of the lungs
  • feeling tired or weak
  • loss of appetite
  • pain that affects different parts of the body - this can range from a sharp pain to a dull ache
  • stiff joints
  • back pain.

Common side effects (may affect up to 1 in 10 people):

  • flu
  • infection of the urinary tract
  • hay fever
  • anxiety
  • loss of weight.

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.

-
CustomerAccord
DescriptionAzacitidine Film Coated Tablets
MarketUK
LanguageEnglish
170 x 550 mm (CMO-SAKAR-PIL)
9
Version No.2 (Page 1 of 2)
Date30_12_2025 (Azacitidine Film Coated Tablets-CMO-SAKAR-TP(ACC-UK)-PIL)

Package leaflet: Information for the patient

Azacitidine 200 mg, 300 mg film-coated tablets

File Name : Azacitidine Film Coated Tablets-CMO-SAKAR-TP(ACC-UK)-PIL

-
CustomerAccord
DescriptionAzacitidine Film Coated Tablets
MarketUK
LanguageEnglish
170 x 550 mm (CMO-SAKAR-PIL)
9
Version No.2 (Page 2 of 2)
Date30_12_2025 (Azacitidine Film Coated Tablets-CMO-SAKAR-TP(ACC-UK)-PIL)

5. How to store Azacitidine

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the blister and the carton after EXP.

The expiry date refers to the last day of that month.

This medicine does not require any special storage conditions.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

6. Contents of the pack and other information

What Azacitidine contains

  • The active substance is azacitidine. Each film-coated tablet contains either 200 mg or 300 mg azacitidine.
  • The other ingredients are mannitol, silicified microcrystalline cellulose, croscarmellose sodium and magnesium stearate.
  • The 200 mg tablet coating: hypromellose (E464), lactose monohydrate, polyethylene glycol (E1521), triacetin (E1518), titanium dioxide (E171), iron oxide red (E172). See section 2 “Azacitidine tablets contain sodium”.
  • The 300 mg tablet coating: hypromellose (E464), lactose monohydrate, polyethylene glycol (E1521), triacetin (E1518), titanium dioxide (E171), iron oxide red (E172), iron oxide yellow (E172), iron oxide black (E172). See section 2 “Azacitidine tablets contain sodium”.

What Azacitidine looks like and contents of the pack

Azacitidine 200 mg film-coated tablets are pink, approximately 17 x 7.6 mm oval shaped film-coated tablets debossed with “MA1” on one side and plain on the other side.

Azacitidine 300 mg film-coated tablets are brown, approximately 19 x 9 mm oval shaped film-coated tablets debossed with “MA2” on one side and plain on the other side.

Azacitidine 200 mg and 300 mg film-coated tablets are available in cartons containing 7 and 14 film-coated tablets in alu-alu blisters or alu/PVC/PCTFE blisters with push through aluminium foil, and in cartons containing 7 x 1 and 14 x 1 film-coated tablets in cross-perforated unit-dose blisters.

Not all pack sizes may be marketed.

Marketing Authorisation Holder

Accord Healthcare Limited

Sage House, 319 Pinner Road

North Harrow, Middlesex

HA1 4HF

United Kingdom

Manufacturers

Accord Healthcare Limited

Sage House, 319 Pinner Road

North Harrow, Middlesex

HA1 4HF, United Kingdom

Accord Healthcare B.V.

Winthontlaan 200

Utrecht, 3526 KV

Netherlands

Accord Healthcare Polska Sp.z.o.o.

ul. Lutomierska 50

Pabianice, 95-200

Poland

Accord Healthcare Single Member S.A.

64th Km National Road Athens,

Lamia, Schimatari, 32009, Greece

Pharmadox Healthcare Limited

KW20A Kordin Industrial Park,

Paola, PLA3000, Malta

This leaflet was last revised in September 2025

If you would like a leaflet with larger text, please contact

01271 385257

File Name : Azacitidine Film Coated Tablets-CMO-SAKAR-TP(ACC-UK)-PIL

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 20075/1596

Last revision stated in the text: September 2025 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Azacitidine 200 mg film-coated tablets

Prescription needed? Yes, prescription-only medicine (POM)
Active substance Azacitidine
Strength 200 mg
Pharmaceutical form Oral tablet
Pink, oval, film-coated tablet, 17.2 x 7.7 mm, debossed with “753” on one side and plain on the other side.
How is it taken Oral
Excipients Croscarmellose sodium (E 468), Magnesium stearate (E 572), Mannitol (E 421), Cellulose, microcrystalline, Silica, colloidal anhydrous, Hypromellose (E 464), Titanium dioxide (E 171), Lactose monohydrate, Macrogol (E 1521), Triacetin (E 1518), Iron oxide red (E 172)
Pack sizes 7 tablet
Is it available? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life 3 years
Storage This medicinal product does not require any special storage conditions.
Drug group (ATC) Antineoplastic agents, antimetabolites, pyrimidine analogues
  1. L Antineoplastic and immunomodulating agents
    1. L01 Antineoplastic agents
      1. L01B Antimetabolites
        1. L01BC Pyrimidine analogues, antineoplastic antimetabolites
          1. L01BC07 azacitidine
Marketing authorisation PL 20075/1596, PL 51289/0028 (first authorised 24 June 2026)
Marketing authorisation holder Adalvo Limited Malta
Codes GTIN 5056842805643 · BNF 08010300

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.1.0 of 12 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.